Email Updates

Search form

You are here

8 FEBRUARY 2019 VOLUME 20 ISSUE 5

Media Coverage

  • In 2013, not quite a year after the Food and Drug Administration approved the drug Truvada for HIV prevention, a coalition of 50 experts in HIV and women's health called on U.S. public health agencies to promote the pill and its approach, called pre-exposure prophylaxis, or PrEP, explicitly to women.

    February 8, 2019
    NPR
  • For now, the details of the administration’s plans are still murky. All we have is a two-page HHS fact sheet to go on. So we asked seven HIV and public health experts to weigh in on what Trump’s plan to end HIV in the US should do if the administration is serious about tackling the ongoing epidemic. Here’s what they told us. Their answers have been lightly edited for clarity.

    February 8, 2019
    General
    Vox
  • A female MP in Tanzania has called for checks to determine whether or not her male colleagues have undergone circumcision - a procedure known to reduce the risk of HIV transmission.

    February 8, 2019
    BBC
  • A non-governmental organization, Aids Healthcare Foundation (AHF) Nigeria distributes over 70,000 condoms and offers HIV testing for 4,000 to the people of Kogi State as part International Condoms Day.

    February 8, 2019
    Daily Trust
  • Eastern Europe continues to have one of the worst HIV epidemics in the world outside sub-Saharan Africa, with the worst linkage to care of any region in the world, last week's meeting on Standard of Care for HIV and Coinfections in Europe heard.

    February 7, 2019
    aidsmap
  • Since its founding in 2002, the Global Fund to Fight AIDS, Tuberculosis and Malaria has become a vital part of the global health architecture. It has disbursed more than $38 billion and saved millions of lives from the world’s top three infectious killers.

    February 7, 2019
    General
    Devex
  • NIH-funded scientists developed an assay that may help researchers measure the success of their HIV cure strategies.

    February 7, 2019
    Healio
  • In his State of the Union address on 5 February, President Donald Trump committed to eliminating HIV in the United States by 2030. Many researchers applauded the sentiment but are sceptical that the administration can effectively reach out to communities that it has helped to marginalize through its actions.

    February 6, 2019
    General
    Nature
  • A Non-Governmental Organisation, Centre for the Right to Health has called for investment in new HIV prevention treatment, Pre- exposure Prophylaxis, (PReP) as it helps in reducing HIV infection.

    February 6, 2019
    Independent
  • Gilead is looking to eventually sub out Truvada for its newer HIV drug Descovy when it comes to pre-exposure prophylaxis. But in the meantime, it’s socking cash into promoting the older brand for PrEP.

    February 6, 2019
    FiercePharma
  • President Donald Trump plans to use Tuesday night’s State of the Union address to promise an end to the HIV epidemic in America, four individuals with knowledge of the planned remarks told POLITICO.

    February 5, 2019
    General
    Politico
  • During the State of the Union address tonight, President Trump is expected to call for an end to the spread of HIV in the U.S. by 2030. There's a drug already on the market that could help make that a reality. It's called Truvada -- otherwise known as PrEP (for Pre-Exposure Prophylaxis) -- and when taken as a preventive, it can drastically reduces transmission of HIV.... The downside? It can cost upward of $1,600 a month.

    February 5, 2019
    Marketplace
  • One of the reasons HIV infection is so hard to prevent and treat is that the virus mutates in order to evade broadly neutralizing antibodies—the immune system’s primary defense against viral pathogens. So scientists at the Fred Hutchinson Cancer Research Center constructed an atlas of HIV mutations, providing insight that they believe will boost the ongoing search for an effective vaccine.

    February 4, 2019
    Fierce Biotech

Published Research

Announcements